INHIBRX LLC has a total of 56 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2012. It filed its patents most often in China, United States and Brazil. Its main competitors in its focus markets pharmaceuticals and biotechnology are MEDEXGEN CO LTD, ARGEN-X N V and APEXIGEN INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 7 | |
#2 | United States | 5 | |
#3 | Brazil | 4 | |
#4 | Canada | 4 | |
#5 | Japan | 4 | |
#6 | Republic of Korea | 4 | |
#7 | WIPO (World Intellectual Property Organization) | 4 | |
#8 | Singapore | 3 | |
#9 | Chile | 2 | |
#10 | Costa Rica | 2 | |
#11 | India | 2 | |
#12 | Mexico | 2 | |
#13 | New Zealand | 2 | |
#14 | Peru | 2 | |
#15 | Philippines | 2 | |
#16 | Australia | 1 | |
#17 | Colombia | 1 | |
#18 | Ecuador | 1 | |
#19 | EPO (European Patent Office) | 1 | |
#20 | Israel | 1 | |
#21 | Nicaragua | 1 | |
#22 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Deveraux Quinn | 43 |
#2 | Nguy Peter L | 31 |
#3 | Eckelman Brendan | 24 |
#4 | Timmer John | 24 |
#5 | Razai Amir | 23 |
#6 | Jones Kyle | 23 |
#7 | Eckelman Brendan P | 19 |
#8 | Timmer John C | 19 |
#9 | Guenther Grant B | 19 |
#10 | Quinn Deveraux | 12 |
Publication | Filing date | Title |
---|---|---|
US2014140989A1 | Non-Platelet Depleting and Non-Red Blood Cell Depleting CD47 Antibodies and Methods of Use Thereof | |
PE20151408A1 | CD47 ANTIBODIES THAT DO NOT EXHAUST PLATELETS OR RED BALLOONS AND METHODS OF USING THEM | |
NZ619035A | Wap domain fusion polypeptides and methods of use thereof |